Could SpaceX's $1.75T Valuation Make It the Biggest Public Offering in History?

SpaceX may file for an IPO within a week, targeting up to $75 billion raised and a valuation as high as $1.75 trillion (≈113x 2025 sales). Analysts’ estimates show revenue growing from $2.3B in 2021 to $15.5B in 2025 (2024 +51%, 2025 +18%), but the proposed valuation would be more than double its last $800B private mark. Reuters reports up to 30% of IPO shares could be allocated to retail, increasing the odds of an initial surge and volatile pullback; the piece recommends waiting for the S-1 and avoiding the IPO until prices normalize.

Analysis

A headline IPO in the aerospace/satellite/AI intersection will reallocate capital, talent and supplier leverage in ways the market underestimates. Expect suppliers with flexible capacity and long-term defense contracts to win incremental order share as investors and customers consolidate around the public market leader; smaller launch/satellite developers face tighter funding and margin pressure as capital chases the perceived ‘category king.’ This will compress public comparables’ forward returns even if underlying revenues remain unchanged, because perception now substitutes for near-term cash generation in multiples.

The near-term calendar risk is front-loaded: IPO pop + heavy retail participation will amplify volatility in days-weeks, followed by lockup expiries and the slow realization that long-cycle programs drive cash flows over years. Regulatory and sovereign procurement timelines create asymmetric downside — a single defense or spectrum ruling can shift multi-year revenue trajectories quickly. On a 3–24 month horizon, monitor aftermarket volume, insider sell patterns, and any acceleration in M&A or supplier exclusive agreements as primary catalysts.

Tradeable dislocations will concentrate in small-cap peers and supplier chains rather than broad semiconductors. Expect a spillover where investors exit speculative satellite/launch names into the IPO; that creates shortable windows and call-buy opportunities on differentiated, cash-generative incumbents. Hedging AI-compute exposure is prudent: if the public leader internalizes more AI stack, incremental external demand for high-margin chips may be lower than consensus expects, increasing idiosyncratic risk for names priced for perpetual growth.

Contrarian stance: the market prices monopoly-duration and execution certainty more than demonstrated cash returns. If you believe execution risk and long timelines dominate, the opportunity is to sell the narrative-driven premium and reallocate into names with nearer-term free cash flow or exposed optionality from weaker competitors losing funding.

Key Decisions for Investors

• Pair trade (3–12 months): Long RKLB (size 1.0–1.5% NAV) / Short ASTS (size 0.5–1.0% NAV). Rationale: capture rerating to the public winner and funding flight from small-cap speculative peers. Target 25–40% upside on the long and 20–30% downside protection on the short; stop-loss at 12% adverse move.
• Options volatility play (0–60 days around IPO): Sell premium in small-cap satellite/launch names (e.g., ASTS) via short 30–90 day ATM call spreads and buy 90–180 day protective puts to monetize expected post-IPO mean reversion and retail-driven spikes. Position size: total vega exposure <0.5% NAV; target theta capture > implied vol decay.
• Supplier capture (12–24 months): Buy selective mid-cap suppliers with defense backlog and diversified customers (size 1–2% NAV). Rationale: benefit from supplier reallocation and higher utilization without paying IPO multiple; target IRR 20%+ if market consolidates.
• Hedge AI-compute exposure (6–18 months): For material NVDA/INTC positions, implement a collar or buy modest-duration puts (3–6 months) representing 2–5% NAV to protect against reduced third-party chip demand if the public leader internalizes AI stack. Aim to cap downside to -10% while retaining upside.